Advair HFA 230-21 MCG inhaler 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26F4FT5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,812
Award facts
- Contract value 100% obligated
- $14,811.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on December 23, 2025, to AmerisourceBergen Drug Corp, represents a competitively awarded, non-set-aside contract for the supply of Advair HFA 230-21 mcg inhalers with a ceiling value of $14,811.64. The contract, which extends through December 24, 2025, is funded by the Defense Logistics Agency (DLA) and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a substantial prime vendor vehicle valued at $999,999,999.00 through December 2026 that enables global pharmaceutical support for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's extensive federal contract portfolio demonstrates its capability to meet DLA's medical supply requirements through open competition. This delivery order for respiratory medication supports the Defense Health Agency and broader military healthcare systems, consistent with AmerisourceBergen's established role as a preferred vendor within the DLA's pharmaceutical supply chain for federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26F4FT5?
SPE2DR26F4FT5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F4FT5 worth?
The government has obligated $14,812 on SPE2DR26F4FT5.
Is contract SPE2DR26F4FT5 an order under another contract?
Yes. SPE2DR26F4FT5 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4FT5 competed?
The extent of competition for SPE2DR26F4FT5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award